How Long Do Benzodiazepines Stay in Your System?

How long benzodiazepines stay in your system depends on which drug you took, how much, how often, and a handful of factors that vary from person to person. There is no single answer that applies to everyone, but there are reliable ranges for each drug and each type of test, and understanding them helps whether you are asking for medical, legal, or treatment-related reasons.

This article covers detection windows by drug and test type, what factors affect how quickly benzos clear the body, and what it means if stopping benzos is something you are thinking about.

How Benzos Work in the Body

Benzodiazepines work by enhancing the activity of GABA, a neurotransmitter that slows down activity in the central nervous system. That calming effect is what makes them useful for anxiety, panic disorder, seizures, and insomnia. It is also what makes them difficult to stop: the brain adapts to their presence and can become dysregulated when the drug clears.

The speed at which a benzodiazepines works and clears is tied to its half-life, which is the time it takes for half the drug to leave the bloodstream. Short-acting benzos clear faster. Long-acting benzos linger. Both can be detected in testing long after the last dose.

Short-Acting vs. Long-Acting Benzodiazepines

Not all benzos behave the same in the body. The half-life varies significantly across the drug class, and that difference matters both clinically and in terms of detection.

Short-acting benzos (half-life under 12 hours) include:

  • Xanax (alprazolam) – half-life 6 to 12 hours
  • Ativan (lorazepam) – half-life 10 to 20 hours
  • Halcion (triazolam) – half-life 1.5 to 5.5 hours

Long-acting benzos (half-life over 24 hours) include:

  • Valium (diazepam) – half-life 20 to 100 hours
  • Klonopin (clonazepam) – half-life 18 to 50 hours
  • Librium (chlordiazepoxide) – half-life 5 to 30 hours

Long-acting benzodiazepines and their active metabolites can remain detectable far longer than the half-life alone suggests. Diazepam, for example, breaks down into desmethyldiazepam, which itself has a long half-life and shows up on drug tests.

Detection Windows by Test Type

Detection depends on both the drug and the type of test used. Here are general ranges for common benzodiazepines by testing method.

Urine Testing

Urine is the most common testing method. Detection windows vary:

  • Short-acting benzos (Xanax, Ativan): 3 to 7 days in most cases
  • Long-acting benzos (Valium, Klonopin): up to 2 to 4 weeks, sometimes longer with heavy use
  • Heavy or chronic use of any benzo: detection windows can extend significantly beyond standard ranges

Blood Testing

Blood tests detect benzos for a shorter window than urine and are typically used in medical or emergency settings rather than routine screening.

  • Short-acting benzos: 6 to 24 hours
  • Long-acting benzos: up to 2 to 3 days

Saliva Testing

Saliva tests are less common for benzos but are used in some settings.

  • Detection window: generally 1 to 10 days depending on the drug and frequency of use

Hair Testing

Hair follicle testing has the longest detection window of any method. Benzos can show up in hair samples for up to 90 days, though detection is less reliable at lower doses.

Factors That Affect How Long Benzos Stay in Your System

The ranges above are general. Several individual factors can shift them significantly in either direction.

Which Benzo You Took

The half-life and whether the drug produces active metabolites matters more than anything else. Valium produces metabolites that are themselves long-acting. Ativan does not, which is part of why it clears more predictably.

Dose and Duration of Use

Someone who took a single low dose will clear the drug faster than someone who has been taking high doses daily for months. With chronic use, benzos accumulate in fatty tissue and clear more slowly.

Age and Metabolism

Metabolism slows with age. Older adults typically process and clear benzos more slowly than younger adults, which also contributes to a higher risk of side effects and accumulation.

Body Composition

Benzos are fat-soluble. People with higher body fat percentages may retain benzos longer because the drug distributes into fatty tissue and is released gradually over time.

Liver Function

The liver processes most benzodiazepines. Liver disease or reduced liver function slows clearance considerably.

Use of Other Substances

Some substances slow benzo metabolism (including certain antifungals and some antidepressants). Alcohol combined with benzos also affects how both substances are processed and increases their combined sedative effect.

What Happens When Benzos Clear the Body

For people who have been using benzos regularly, clearance of the drug is not simply a return to baseline. Because the brain has adapted to the drug’s presence, its absence can trigger a rebound effect. This is why benzo withdrawal requires careful clinical attention rather than abrupt stopping.

The experience of withdrawal varies based on which benzo was used, how long, and at what dose. Short-acting benzos like Xanax can produce withdrawal symptoms relatively quickly after the last dose. Long-acting benzos like Valium may not produce noticeable symptoms for a day or two.

Understanding that timeline is different from understanding when the drug clears a test. Feeling the effects of withdrawal is not the same as the drug being gone from the system, and the drug being gone from the system does not mean the body has fully recalibrated. Our benzodiazepine withdrawal timeline covers what that process typically looks like in more detail.

Thinking About Stopping Benzos?

If you are asking how long benzos stay in your system because stopping is something you are considering, that is worth taking seriously from a medical standpoint. Stopping benzos abruptly, particularly after prolonged use, carries risks that make clinical guidance important.

A clinical assessment helps determine what level of support is appropriate based on your specific history. ASAM guidelines help providers evaluate the right setting for withdrawal management, whether that is outpatient monitoring, a taper protocol, or inpatient residential care.

At Greylock Recovery, we offer benzodiazepine addiction treatment in a residential inpatient setting in Williamstown, Massachusetts. Our clinical team builds individualized plans that address withdrawal, co-occurring conditions, and what recovery looks like beyond the residential stay. Medication-assisted treatment is part of our toolkit, incorporated into plans where it is clinically appropriate.

If you want to understand your options before making any decisions, our admissions team is available to talk. You can also verify your insurance confidentially before your first call. Reach us at (413) 269-8387. There is no pressure. Just information, and someone ready to listen.

Frequently Asked Questions

How long does Xanax stay in your urine?

Xanax typically stays detectable in urine for 3 to 7 days after the last dose in occasional users. With regular or heavy use, detection can extend beyond that range. Individual factors including metabolism, age, and body composition also affect the result.

Can benzos show up on a drug test after 30 days?

For long-acting benzos like Valium, detection beyond 30 days is possible with heavy or prolonged use, particularly in urine. Hair testing can detect benzos for up to 90 days. Short-acting benzos in occasional users are unlikely to be detectable beyond 7 to 10 days in urine.

Do prescribed benzos show up the same as unprescribed ones on a test?

A drug test does not distinguish between prescribed and unprescribed benzodiazepines. A valid prescription disclosed before the test is handled through the testing or review process, not detected differently by the test itself.

Is it safe to stop taking benzos on your own?

Stopping benzos abruptly, particularly after regular or prolonged use, carries a risk of medically serious withdrawal including seizure. Clinical guidance on how to stop safely is important. The appropriate setting for stopping depends on individual factors and is worth discussing with a healthcare provider or addiction medicine specialist.

Ready to talk about your options? Reach our admissions team at (413) 269-8387, or verify your insurance to get started.

Call to Connect

You don’t have to be ready for everything. You just have to be ready for one step.

Call Our Free

24 Hour Helpline
Get The Help You Need
Counselors are standing by

Jody Kocsis is a dependable team member dedicated to maintaining a safe, clean, and efficient facility environment. With a strong attention to detail and a commitment to quality, Jody supports daily operations and ensures a positive experience for all.

Eric Simmons is the Director of Case Management at Greylock Recovery, bringing more than 15 years of experience in behavioral health, substance use disorder treatment, residential programming, admissions, and case management. He has led program operations, patient advocacy initiatives, staff development, and outcome improvement efforts across residential and human service settings.

Prior to Greylock Recovery, Eric served as Director of Residential and Admissions Services for a local Berkshire county recovery facility, overseeing residential operations, admissions, referral development, and regulatory compliance. His expertise includes case management, discharge planning, community resource development, compliance, and staff training.

Eric earned a Bachelor of Arts in Sociology from Westfield State University, graduating Magna Cum Laude. He is committed to helping individuals overcome barriers to recovery and achieve lasting stability, while also serving his community as a youth football coach and mentor.

Jennifer Parsons is a seasoned human resources executive with more than 15 years of experience leading strategic HR initiatives, talent management, employee relations, and organizational development. Most recently, she served as Senior Vice President of Human Resources at Pittsfield Cooperative Bank, where she played a key role in fostering a positive workplace culture and supporting the organization’s growth and success.

Jennifer holds the Senior Professional in Human Resources (SPHR) certification from the Human Resource Certification Institute (HRCI), demonstrating her expertise and commitment to excellence in the HR profession. She also earned an associate’s degree in both Business Administration and Hospitality Administration, providing a strong foundation in leadership, operations, and customer service.

A Berkshire County native, Jennifer is deeply committed to her community and currently resides in the region with her family. In addition to her professional accomplishments, she serves on the Board of Directors for the Gladys Allen Brigham Center in Pittsfield, supporting the organization’s mission to empower women and strengthen the Community.

Jennifer Walker has been caring for others since 1989, starting out as a nurse’s aide and working her way through roles as a medical assistant, LPN, and RN. Along the way, she earned an associate’s degree in business administration and gathered an impressive range of experience—from primary care and long-term care to neurosurgery, neurology, colorectal surgery, orthopedics, and hospital-based surgical services. She’s also spent seven years helping individuals overcome substance use disorders, including time as a Director of Nursing, and has worked in hospice and with patients with disabilities.

But Jennifer’s dedication to people goes far beyond the workplace. A former foster parent and active supporter of local charities, she pours her heart into her community. When she’s not in scrubs, you can find her cheering at a sports game, tending to her garden, or enjoying laughter-filled moments with her family. Her blend of skill, heart, and positivity makes her not just a caregiver, but a true bright light for everyone she meets.

Elizabeth Azzariti, LICSW,

Elizabeth Azzariti, LICSW, is a seasoned clinical leader with over 10 years of experience in treating behavioral and addiction issues. After a successful 25-year career in the insurance industry, where she advanced to VP of Finance and Administration, she returned to school, earned her Master of Social Work from Wheelock College, and launched a new career dedicated to behavioral health. In her new role as Clinical Director at Greylock Recovery, she brings deep expertise in clinical operations, program development, and multidisciplinary team leadership. Most recently, as Executive Director at Nulife Behavioral Health, she served as both Clinical and Executive Director, leading the launch of PHP, IOP, TMS, Alumni, and Family programs while overseeing clinical staff hiring, supervision, and operations. She designed and implemented a 16-week evidence-based curriculum for co-occurring disorders that boosted attendance, retention, and patient outcomes. Her prior leadership roles include Clinical Supervisor at Blue Hills Recovery—directing multidisciplinary teams across PHP, IOP, and 24/7 residential programs—and at New England Recovery Center. EMDR-trained and specializing in trauma-informed care and integrated treatment, Elizabeth is passionate about delivering high-quality clinical care that supports lasting recovery for individuals and families.

Flora Sadri-Azarbayejani’s journey in the field of healthcare began at Boston University, where she earned her undergraduate degree in biomedical engineering.

Dr. Sadri-Azarbayejani pursued dual master’s degrees at Boston University, specializing in epidemiology and biostatistics, and medical science. She then attained her doctorate in medicine from the University of New England College of Osteopathic Medicine. Dr. Sadri-Azarbayejani’s professional career commenced as an epidemiologist in infectious disease at the Massachusetts Department of Public Health.

Eventually appointed as the Chief Medical Officer.She became board certified in addiction medicine and worked in the addiction space since 2014. She has worked both inpatient and outpatient addiction medicine. Opening programs in both arenas.

Currently serves as the medical director for substance use services at Lowell Community Health Center and for an inpatient addiction treatment center. Dr. Sadri-Azarbayejani is an active and engaged member of various medical societies, including the Massachusetts Medical Society, the American Academy of Family Physicians (AAFP), and the American Society of Addiction Medicine (ASAM).

Involved with development of CARF guidelines for outpatient addiction treatment programs. She also hopes to make an impact on passing legislation of supervised consumption sites in the near future.

Lauren Temple is a Licensed Clinical Social Worker (LICSW) bringing over 15 years of dedicated leadership in the behavioral health sector, with extensive expertise spanning inpatient, outpatient, and substance use disorder programming. She obtained her Master of Science in Social Administration from Case Western Reserve University and holds dual licensure as an LICSW in Massachusetts and an LISW-S in Ohio. Serving as the Executive Director for Greylock Recovery, Lauren manages clinical operations, regulatory adherence, and strategic growth to uphold the highest standards of patient-centric treatment.

Her professional background includes directing diverse clinical teams, broadening service accessibility, and overseeing quality improvement efforts while navigating complex accreditation and state regulatory cycles. Lauren remains deeply invested in cultivating elite clinical staff, improving recovery metrics, and championing evidence-based advancements in behavioral health care.